OR51F2

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, OR51F2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR51F2’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where OR51F2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR51F2 is over-expressed in tumor.

PRAD are the cancer types where OR51F2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR51F2 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
PRADAllAll+0.191<.0012view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

OR51F2–PRAD

Tumor-vs-normal expression box plot for OR51F2 RNA in PRAD.

Open the PRAD breakdown →

Exploration